Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practice
Ambre Lauret, Anna Moltó, Véred Abitbol, Loriane Gutermann, Ornella Conort, François Chast, Claire Goulvestre, Claire Le Jeunne, Stanislas Chaussade, Christian Roux, Frédéric Batteux, Maxime Dougados, Yannick Allanore, Jérôme Avouac
Topics & Concepts
BiosimilarMedicineInfliximabDiscontinuationImmunogenicityCohortInternal medicineCohort studyObservational studyIncidence (geometry)SurgeryImmunologyAntibodyTumor necrosis factor alphaOpticsPhysicsBiosimilars and Bioanalytical MethodsInflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies